Put Options

6 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2023

May 15, 2023

SELL
$135.66 - $197.02 $13.4 Million - $19.5 Million
-99,100 Reduced 70.94%
40,600 $6.24 Million
Q4 2022

Feb 14, 2023

BUY
$118.38 - $210.04 $2.2 Million - $3.91 Million
18,600 Added 15.36%
139,700 $25.1 Million
Q3 2022

Nov 14, 2022

BUY
$118.07 - $194.18 $1.38 Million - $2.27 Million
11,700 Added 10.69%
121,100 $14.3 Million
Q2 2022

Aug 15, 2022

BUY
$117.13 - $176.59 $8.54 Million - $12.9 Million
72,900 Added 199.73%
109,400 $15.6 Million
Q1 2022

May 16, 2022

BUY
$126.46 - $235.05 $4.3 Million - $7.99 Million
34,000 Added 1360.0%
36,500 $6.29 Million
Q4 2021

Feb 14, 2022

BUY
$225.82 - $368.51 $564,550 - $921,275
2,500 New
2,500 $634,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.